The prognostic significance of malignant pleural effusion at the time of thoracotomy in patients with non-small cell lung cancer

被引:31
作者
Fukuse, T
Hirata, T
Tanaka, F
Wada, H
机构
[1] Otsu Red Cross Hosp, Dept Thorac Surg, Otsu, Shiga 5208511, Japan
[2] Kyoto Univ, Fac Med, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan
关键词
lung cancer; pleural effusion; pleural dissemination; surgery; prognosis; multivariate analysis;
D O I
10.1016/S0169-5002(01)00228-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surgery is usually not indicated for malignant pleural effusion (PE) due to its poor prognosis. However, PE is first detected at thoracotomy, and it is difficult to judge an appropriate mode of resection. Forty-nine patients with lung cancer were first diagnosed as PE and/or pleural dissemination (PD) at thoracotomy. The histological types were 36 adenocarcinoma, ten squamous cell carcinoma and three large cell carcinoma. Sixteen patients had only PE, 17 had only PD, and 16 had both PE and PD. Ten patients underwent only exploratory thoracotomy, seven partial resection, 27 lobectomy and five panpleuropneumonectomy. The overall survival rate was 26.7% at 3 years. The patients with PE and/or PD seemed to have a poorer survival compared to our previous study. The patients with only PE showed a significantly better prognosis than the patients with only PD (P=0.0001) or with PD + PE (P=0.019). The patients who underwent exploratory thoracotomy showed poor survival. There were significant differences in the survival in relation to the extent of the primary tumor. In conclusion, the patients with T1-2 of primary tumor and only a small amount of PE without PD can be expected to show long-term survival after tumor resection. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 20 条
[1]   Impact of revised stage classification of lung cancer on survival - A military experience [J].
Adebonojo, SA ;
Bowser, AN ;
Moritz, DM ;
Corcoran, PC .
CHEST, 1999, 115 (06) :1507-1513
[2]   PLEURAL DISSEMINATION IN NONSMALL CELL LUNG-CANCER - RESULTS OF RADIOLOGICAL EVALUATION AND SURGICAL-TREATMENT [J].
AKAOGI, E ;
MITSUI, K ;
ONIZUKA, M ;
ISHIKAWA, S ;
TSUKADA, H ;
MITSUI, T .
JOURNAL OF SURGICAL ONCOLOGY, 1994, 57 (01) :33-39
[3]   LUNG-CANCER AND PLEURAL EFFUSION - CLINICAL-SIGNIFICANCE AND STUDY OF PLEURAL METASTATIC LOCATIONS [J].
CANTO, A ;
FERRER, G ;
ROMAGOSA, V ;
MOYA, J ;
BERNAT, R .
CHEST, 1985, 87 (05) :649-652
[4]   Multimodality therapy in stage III non-small cell lung cancer [J].
Edelman, MJ ;
Gandara, DR ;
Roach, M ;
Benfield, JR .
ANNALS OF THORACIC SURGERY, 1996, 61 (05) :1564-1572
[5]   HYPOTONIC CISPLATIN TREATMENT FOR CARCINOMATOUS PLEURITIS FOUND AT THORACOTOMY IN PATIENTS WITH LUNG-CANCER - INVITRO EXPERIMENTS AND PRELIMINARY CLINICAL-RESULTS [J].
ICHINOSE, Y ;
HARA, N ;
OHTA, M ;
ASOH, H ;
YANO, T ;
MAEDA, K ;
YAGAWA, K .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 105 (06) :1041-1046
[6]   Prognosis of non-small cell lung cancer patients with positive pleural lavage cytology after a thoracotomy: results of the survey conducted by the Japan Clinical Oncology Group [J].
Ichinose, Y ;
Tsuchiya, R ;
Yasumitsu, T ;
Koike, T ;
Yamato, Y ;
Nakagawa, K ;
Tada, H ;
Yokoi, K ;
Nagai, K ;
Kase, M .
LUNG CANCER, 2001, 31 (01) :37-41
[7]  
ISHIDA T, 1995, INT SURG, V80, P70
[8]  
KELLER SM, 1993, CHEST, V103, pS63, DOI 10.1378/chest.103.1_Supplement.63S
[9]  
KODAMA K, 1993, CANCER, V72, P426, DOI 10.1002/1097-0142(19930715)72:2<426::AID-CNCR2820720218>3.0.CO
[10]  
2-S